Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Teruel

4 clinical trials in Teruel, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Teruel at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

4 trials in Teruel

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:Fundacion Instituto De Investigacion Sanitaria Aragon
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tinzaparin Sodium
  • Sponsor:Grupo Gallego De Investigacion En Tumores Digestivos

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Teruel

What the registry says about research in the country

01 Oncology Research

Investigating preventive measures for venous thromboembolic disease in patients with metastatic colorectal cancer. The research focuses on evaluating prophylactic treatments during first-line therapy.

  • Colorectal Cancer Management
  • Thrombosis Prevention
  • Systemic Treatment Optimization

Studies aim to improve patient outcomes during chemotherapy and targeted therapy combinations.

02 Gastroenterology Studies

Examining the safety of cold snare polypectomy procedures in patients maintaining anticoagulant and antiplatelet therapies. Research focuses on minimizing bleeding risks during routine colonoscopy procedures.

  • Polyp Removal Techniques
  • Bleeding Risk Assessment
  • Anticoagulation Management

The research aims to establish safer protocols for patients requiring ongoing blood-thinning medications.

03 Breast Cancer Research

Evaluating extended therapy with camizestrant in ER+/HER2- early breast cancer patients. The study focuses on preventing cancer recurrence after standard adjuvant endocrine therapy.

  • Extended Therapy Efficacy
  • Recurrence Prevention
  • Endocrine Treatment Innovation

This research represents advancement in personalized treatment approaches for breast cancer patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.